Improving treatment of children with acute lymphoblastic leukemia in developing countries through technology sharing,

Gaston K Rivera1, Raul C Ribeiro

  • 1International Outreach Program and Department of Oncology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.

Expert Review of Hematology
|September 2, 2014
PubMed

Insights

Cure rates for pediatric acute lymphoblastic leukemia (ALL) vary globally. This study suggests using communication technology to foster partnerships and improve ALL treatment in developing nations, reducing mortality.

Area of Science:

  • Pediatric Oncology
  • Global Health Equity

Background:

  • Cure rates for pediatric acute lymphoblastic leukemia (ALL) significantly differ between high- and low-income countries.
  • Limited hospital infrastructure and resources in lower-income nations contribute to higher treatment-related mortality and suboptimal patient compliance.
  • Current upfront risk assignment strategies for individualizing ALL therapy require technical resources and expertise often unavailable in resource-limited settings.

Purpose of the Study:

  • To provide evidence-based suggestions for managing childhood ALL in developing countries.
  • To explore the role of communication technology in improving pediatric oncology care.
  • To enhance patient outcomes by optimizing resource allocation and treatment intensity.

Main Methods:

  • Literature review and synthesis of current management strategies for childhood ALL.
  • Analysis of challenges faced in resource-limited settings for pediatric cancer treatment.
  • Proposal of collaborative models utilizing communication technology for knowledge and resource sharing.

Main Results:

  • Disparities in ALL cure rates are linked to socioeconomic factors and healthcare infrastructure.
  • Effective management requires adapting treatment protocols to local capabilities.
  • Collaborative partnerships can facilitate access to expertise and resources, improving patient care.

Conclusions:

  • Implementing communication technology is crucial for sustaining international pediatric oncology partnerships.
  • Collaborations should focus on prioritizing resources, identifying local challenges, and tailoring treatment intensity.
  • These strategies aim to reduce treatment-related morbidity and mortality, particularly for lower-risk pediatric ALL patients.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.7K